Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Design Therapeutics, Inc. | 6,526,476 | 6,526,476 | 0 | 35,112 | 40,268 | 9.82% | +5,156 |
| KALA Bio, Inc. | 443,661 | 598,940 | +155,279 | 2,529 | 4,157 | 1.01% | +1,628 |
| Mineralys Therapeutics Inc.(MLYS) | 2,016,822 | 2,016,822 | 0 | 24,424 | 24,827 | 6.05% | +403 |
| enGene Holdings Inc. COM | 747,750 | 747,750 | 0 | 4,935 | 4,973 | 1.21% | +37 |
| Oruka Therapeutics, Inc(ORKA) | 375,330 | 430,330 | +55,000 | 9,199 | 8,344 | 2.03% | -855 |
| Alumis Inc. | 1,959,896 | 1,959,896 | 0 | 20,932 | 15,405 | 3.76% | -5,527 |
| Nkarta, Inc. | 3,333,333 | 3,333,333 | 0 | 15,067 | 8,300 | 2.02% | -6,767 |
| CRISPR Therapeutics AG(CRSP) | 1,048,951 | 1,048,951 | 0 | 49,280 | 41,287 | 10.07% | -7,993 |
| ARS Pharmaceuticals, Inc. | 4,012,903 | 4,012,903 | 0 | 58,187 | 42,336 | 10.32% | -15,851 |
| Arcellx, Inc. COMMON STOCK | 2,346,630 | 2,346,630 | 0 | 195,967 | 179,963 | 43.88% | -16,004 |
| Zenas BioPharma, Inc(ZBIO) | 4,911,539 | 4,911,539 | 0 | 83,103 | 40,226 | 9.81% | -42,878 |